Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Real Estate Companies: Alexandria Equities (ARE) and Essex Property (ESS)

Tipranks - Wed Jan 28, 8:32AM CST

Analysts fell to the sidelines weighing in on Alexandria Equities (AREResearch Report) and Essex Property (ESSResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Claim 50% Off TipRanks Premium

Alexandria Equities (ARE)

In a report released today, Ronald Kamdem from Morgan Stanley maintained a Hold rating on Alexandria Equities, with a price target of $55.00. The company’s shares closed last Monday at $57.16.

According to TipRanks.com, Kamdem is a 4-star analyst with an average return of 9.3% and a 59.7% success rate. Kamdem covers the NA sector, focusing on stocks such as American Healthcare REIT, Inc., National Storage Affiliates, and Hudson Pacific Properties. ;'>

Currently, the analyst consensus on Alexandria Equities is a Moderate Buy with an average price target of $51.69, representing a -13.1% downside. In a report issued on January 13, TipRanks – DeepSeek also upgraded the stock to Hold with a $51.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Essex Property (ESS)

Wells Fargo analyst James Feldman maintained a Hold rating on Essex Property today and set a price target of $268.00. The company’s shares closed last Monday at $252.93.

According to TipRanks.com, Feldman is a 1-star analyst with an average return of -0.3% and a 47.4% success rate. Feldman covers the NA sector, focusing on stocks such as Hudson Pacific Properties, Xenia Hotels & Resorts, and Apple Hospitality REIT. ;'>

Essex Property has an analyst consensus of Hold, with a price target consensus of $282.13, implying a 10.4% upside from current levels. In a report issued on January 13, Barclays also maintained a Hold rating on the stock with a $292.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.